FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johannes Peterse

Research Profile

Disorders

Procedures

Anatomy

Concepts & Ideas

Chemicals & Drugs

Biological Tumor Markers

Co-author Network

Publications

TOP 3
Annemarie C Schmitz; Maurice A A J van den Bosch; Claudette E Loo; Willem P Th M Mali; Harry Bartelink; Maria Gertenbach; Roland Holland; Johannes L Peterse; E J Th Rutgers; Kenneth G A Gilhuijs
Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy.
Heather A Jones; Ninja Antonini; Augustinus A M Hart; Johannes L Peterse; Jean-Claude Horiot; Françoise Collin; Philip Poortmans; S Bing Oei; Laurence Collette; Henk Struikmans; Walter Van den Bogaert; Alain Fourquet; Jos Jager; Dominic A X Schinagl; Carla C Wárlám-Rodenhuis; Harry Bartelink
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
Jolien M Bueno-de-Mesquita; Sabine C Linn; R Keijzer; Jelle Wesseling; Dimitry S A Nuyten; C van Krimpen; C Meijers; P W de Graaf; M M E M Bos; A A M Hart; E J Th Rutgers; Johannes L Peterse; H Halfwerk; R de Groot; A Pronk; Arno N Floore; Annuska M Glas; Laura J van't Veer; Marc J van de Vijver
Validation of 70-gene prognosis signature in node-negative breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johannes Peterse (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Annemarie C Schmitz; Maurice A A J van den Bosch; Claudette E Loo; Willem P Th M Mali; Harry Bartelink; Maria Gertenbach; Roland Holland; Johannes L Peterse; E J Th Rutgers; Kenneth G A Gilhuijs
Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;97(2):225-32.
2009: Heather A Jones; Ninja Antonini; Augustinus A M Hart; Johannes L Peterse; Jean-Claude Horiot; Françoise Collin; Philip Poortmans; S Bing Oei; Laurence Collette; Henk Struikmans; Walter Van den Bogaert; Alain Fourquet; Jos Jager; Dominic A X Schinagl; Carla C Wárlám-Rodenhuis; Harry Bartelink
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):4939-47.
2009: Jolien M Bueno-de-Mesquita; Sabine C Linn; R Keijzer; Jelle Wesseling; Dimitry S A Nuyten; C van Krimpen; C Meijers; P W de Graaf; M M E M Bos; A A M Hart; E J Th Rutgers; Johannes L Peterse; H Halfwerk; R de Groot; A Pronk; Arno N Floore; Annuska M Glas; Laura J van't Veer; Marc J van de Vijver
Validation of 70-gene prognosis signature in node-negative breast cancer.
Breast cancer research and treatment 2009;117(3):483-95.
2009: Simon A Joosse; Erik H van Beers; Ivon H G Tielen; Hugo Horlings; Johannes L Peterse; Nicoline Hoogerbrugge; M J L Ligtenberg; Lodewyk F A Wessels; Priscilla Axwijk; Senno Verhoef; Frans B L Hogervorst; petra nederlof
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
Breast cancer research and treatment 2009;116(3):479-89.
2009: K E Pengel; Claudette E Loo; H Jelle Teertstra; Sara H Muller; Jelle Wesseling; Johannes L Peterse; Harry Bartelink; E J Th Rutgers; K G A Gilhuijs
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study.
Breast cancer research and treatment 2009;116(1):161-9.
2009: Marleen Kok; Sabine C Linn; Ryan Van Laar; maurice jansen; Teun M van den Berg; Leonie J M J Delahaye; Annuska M Glas; Johannes L Peterse; Michael Hauptmann; John A Foekens; Jan G M Klijn; Lodewyk F A Wessels; Laura J van't Veer; Petronella Berns
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Breast cancer research and treatment 2009;113(2):275-83.
2008: Cheng-Han Lee; Inigo Espinosa; Suzan Vrijaldenhoven; Subbaya Subramanian; Kelli D Montgomery; Shirley Zhu; Robert J Marinelli; Johannes L Peterse; Neal Poulin; Torsten O Nielsen; Robert B West; C Blake Gilks; Matt van de Rijn
Prognostic significance of macrophage infiltration in leiomyosarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1423-30.
2008: Ph Meijnen; Johannes L Peterse; Ninja Antonini; E J Th Rutgers; Marc J van de Vijver
Immunohistochemical categorisation of ductal carcinoma in situ of the breast.
British journal of cancer 2008;98(1):137-42.
2008: Anne-Marie Cleton-Jansen; Ronald van Eijk; Marcel Lombaerts; Marjanka K Schmidt; Laura J van't Veer; Katja Philippo; Rhyenne M E Zimmerman; Johannes L Peterse; Vincent T B H M Smit; Tom van Wezel; Cees J Cornelisse
ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
BMC cancer 2008;8():105.
2008: Ph Meijnen; Hester S A Oldenburg; Johannes L Peterse; Harry Bartelink; E J Th Rutgers
Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Annals of surgical oncology 2008;15(1):235-43.
2007: Jolien M Bueno-de-Mesquita; Wim H van Harten; Valesca P Retel; Laura J van't Veer; Frits S A M van Dam; Kim Karsenberg; Kirsten F L Douma; Harm van Tinteren; Johannes L Peterse; Jelle Wesseling; Tin S Wu; Douwe Atsma; E J Th Rutgers; Guido Brink; Arno N Floore; Annuska M Glas; R M H Roumen; Frank E Bellot; Cees van Krimpen; Sjoerd Rodenhuis; Marc J van de Vijver; Sabine C Linn
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
The lancet oncology 2007;8(12):1079-87.
2007: Malcolm M Hayes; Johannes L Peterse; Ekrem Yavuz; Gisela H Vischer; Vincenzo Eusebi
Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
The American journal of surgical pathology 2007;31(9):1414-9.
2007: Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; RICCARDO ARISIO; Johannes L Peterse; Anna Sapino; Isabella Castellano; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker; Manuela Lacerda; Paulo Figueiredo
Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients.
American journal of surgery 2007;194(3):288-93.
2007: Ph Meijnen; Hester S A Oldenburg; Claudette E Loo; Omgo E Nieweg; Johannes L Peterse; E J Th Rutgers
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
The British journal of surgery 2007;94(8):952-6.
2007: Xiaoling Liu; Henne Holstege; Hanneke van der Gulden; Marcelle Treur-Mulder; John Zevenhoven; Arno Velds; Ron Kerkhoven; Martin H van Vliet; Lodewyk F A Wessels; Johannes L Peterse; Anton Berns; Jos Jonkers
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(29):12111-6.
2007: Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; RICCARDO ARISIO; Rita Bori; Johannes L Peterse; Anna Sapino; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker
Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis.
European journal of cancer (Oxford, England : 1990) 2007;43(9):1407-14.
2007: Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; RICCARDO ARISIO; Rita Bori; Johannes L Peterse; Anna Sapino; Isabella Castellano; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker; Manuela Lacerda; Paulo Figueiredo; Gábor Fejes
Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study.
Pathology oncology research : POR 2007;13(1):5-14.
2007: Tanja Alderliesten; Angelique Schlief; Johannes L Peterse; Claudette Loo; H Jelle Teertstra; Sara Muller; Kenneth G A Gilhuijs
Validation of semiautomatic measurement of the extent of breast tumors using contrast-enhanced magnetic resonance imaging.
Investigative radiology 2007;42(1):42-9.
2007: Marjanka K Schmidt; R A E M Tollenaar; Sanne Martens-de Kemp; Annegien Broeks; Cees J Cornelisse; Vincent T H B M Smit; Johannes L Peterse; Flora E van Leeuwen; Laura J van't Veer
Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):64-9.
2006: Reini Kaas; R Kroger; Johannes L Peterse; Augustinus A M Hart; Sara H Muller
The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls.
European radiology 2006;16(12):2842-8.
2006: Patrick W B Derksen; Xiaoling Liu; Francis Saridin; Hanneke van der Gulden; John Zevenhoven; Bastiaan Evers; Judy van Beijnum; Arjan W Griffioen; Jacqueline Vink; Paul Krimpenfort; Johannes L Peterse; Robert Cardiff; Anton Berns; Jos Jonkers
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.
Cancer cell 2006;10(5):437-49.
2006: Maartje C van Rijk; H Jelle Teertstra; Johannes L Peterse; Omgo E Nieweg; Renato A Valdés Olmos; Cornelis A Hoefnagel; Bin B R Kroon
Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy.
Annals of surgical oncology 2006;13(11):1511-6.
2006: Maartje C van Rijk; Johannes L Peterse; Omgo E Nieweg; Hester S A Oldenburg; E J Th Rutgers; Bin B R Kroon
Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
Cancer 2006;107(3):467-71.
2006: Nina Bijker; Ph Meijnen; Johannes L Peterse; Jan Bogaerts; Irène Van Hoorebeeck; Jean-Pierre Julien; Massimiliano Gennaro; Philippe Rouanet; Antoine Avril; Ian S Fentiman; Harry Bartelink; E J Th Rutgers
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3381-7.
2006: L N Broekhuizen; J H Wijsman; Johannes L Peterse; E J Th Rutgers
The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2006;32(5):502-6.
2006: Sjoerd Rodenhuis; Marijke Bontenbal; Q G C M van Hoesel; W M Smit; Marianne A Nooij; Emile E Voest; ELSKEN VAN DER WALL; Pierre Hupperets; Harm van Tinteren; Johannes L Peterse; Marc J van de Vijver; E G E de Vries
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):588-96.
2006: Eline E Deurloo; William F A Klein Zeggelink; H Jelle Teertstra; Johannes L Peterse; E J Th Rutgers; Sara H Muller; Harry Bartelink; Kenneth G A Gilhuijs
Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients.
European radiology 2006;16(3):692-701.
2006: Juliane Hannemann; Arno Velds; Johannes B G Halfwerk; Bas Kreike; Johannes L Peterse; Marc J van de Vijver
Classification of ductal carcinoma in situ by gene expression profiling.
Breast cancer research : BCR 2006;8(5):R61.
2006: Maartje C van Rijk; Eline E Deurloo; Omgo E Nieweg; Kenneth G A Gilhuijs; Johannes L Peterse; E J Th Rutgers; Robert Kröger; Bin B R Kroon
Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy.
Annals of surgical oncology 2006;13(1):31-5.
2005: Marina Del Vecchio; Maria P Foschini; Johannes L Peterse; Vincenzo Eusebi
Lobular carcinoma of the breast with hybrid myoepithelial and secretory ("myosecretory") cell differentiation.
The American journal of surgical pathology 2005;29(11):1530-6.
2005: Britta Weigelt; Lodewyk F A Wessels; Astrid J Bosma; Annuska M Glas; Dimitry S A Nuyten; Yudong D He; Hongyue Dai; Johannes L Peterse; Laura J van't Veer
No common denominator for breast cancer lymph node metastasis.
British journal of cancer 2005;93(8):924-32.
2005: Ph Meijnen; Johannes L Peterse; Hester S A Oldenburg; Leonie A E Woerdeman; E J Th Rutgers
Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(8):833-9.
2005: Britta Weigelt; Johannes L Peterse; Laura J van 't Veer
Breast cancer metastasis: markers and models.
Nature reviews. Cancer 2005;5(8):591-602.
2005: Eline E Deurloo; Johannes L Peterse; E J Th Rutgers; A P E Besnard; Sara H Muller; Kenneth G A Gilhuijs
Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis.
European journal of cancer (Oxford, England : 1990) 2005;41(10):1393-401.
2005: Eline E Deurloo; Sara H Muller; Johannes L Peterse; A P E Besnard; Kenneth G A Gilhuijs
Clinically and mammographically occult breast lesions on MR images: potential effect of computerized assessment on clinical reading.
Radiology 2005;234(3):693-701.
2005: Marie-Louise F Van Velthuysen; Babs G Taal; J J M van der Hoeven; Johannes L Peterse
Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma.
Histopathology 2005;46(2):153-7.
2004: Ian F Faneyte; Johannes L Peterse; Harm van Tinteren; Corina Pronk; Marijke Bontenbal; Louk V A M Beex; ELSKEN VAN DER WALL; Dick J Richel; Marianne A Nooij; Emile E Voest; Pierre Hupperets; Elisabeth M Ten Vergert; Elisabeth G E de Vries; Sjoerd Rodenhuis; Marc J van de Vijver
Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4457-63.
2004: Rolf J Postema; Marie-Louise F Van Velthuysen; Michiel van den Brekel; Alfons J M Balm; Johannes L Peterse
Accuracy of fine-needle aspiration cytology of salivary gland lesions in the netherlands cancer institute.
Head & neck 2004;26(5):418-24.
2004: Claudia M G Keyzer-Dekker; Richard G Houtkamp; Johannes L Peterse; Frits van Coevorden
Adult pelvic sarcomas: a heterogeneous collection of sarcomas?
Sarcoma 2004;8(1):19-24.
2003: Britta Weigelt; Annuska M Glas; Lodewyk F A Wessels; Anke T Witteveen; Johannes L Peterse; Laura J van't Veer
Gene expression profiles of primary breast tumors maintained in distant metastases.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15901-5.
2003: Els C Robanus-Maandag; Cathy A J Bosch; Petra M P Kristel; Augustinus A M Hart; Ian F Faneyte; petra nederlof; Johannes L Peterse; Marc J van de Vijver
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
The Journal of pathology 2003;201(1):75-82.
2003: Catherina S P van Rijswijk; Maartje J A Geirnaerdt; Pancras Hogendoorn; Johannes L Peterse; Frits van Coevorden; Antonie H M Taminiau; R A E M Tollenaar; Bin B R Kroon; Johan L Bloem
Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results.
European radiology 2003;13(8):1849-58.
2003: Bradley R Pieters; Augustinus A M Hart; Nicola S Russell; Edwin P M Jansen; Johannes L Peterse; Jacques H Borger; E J Th Rutgers
A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(2):159-64.
2003: Eline E Deurloo; Pieter J Tanis; Kenneth G A Gilhuijs; Sara H Muller; Robert Kröger; Johannes L Peterse; E J Th Rutgers; Renato A Valdés Olmos; Leo J Schultze Kool
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1068-73.
2003: Susanne H Estourgie; Omgo E Nieweg; Renato A Valdés Olmos; E J Th Rutgers; Johannes L Peterse; Bin B R Kroon
Eight false negative sentinel node procedures in breast cancer: what went wrong?
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(4):336-40.
2003: Reini Kaas; Johannes L Peterse; Augustinus A M Hart; A C Voogd; E J Th Rutgers; Flora E van Leeuwen
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer.
British journal of cancer 2003;88(5):707-10.
2003: Ian F Faneyte; JG Schrama; Johannes L Peterse; P L Remijnse; Sjoerd Rodenhuis; Marc J van de Vijver
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome.
British journal of cancer 2003;88(3):406-12.
2002: Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke T Witteveen; Annuska M Glas; Leonie J M J Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
A gene-expression signature as a predictor of survival in breast cancer.
The New England journal of medicine 2002;347(25):1999-2009.
2002: Kenneth G A Gilhuijs; Eline E Deurloo; Sara H Muller; Johannes L Peterse; Leo J Schultze Kool
Breast MR imaging in women at increased lifetime risk of breast cancer: clinical system for computerized assessment of breast lesions initial results.
Radiology 2002;225(3):907-16.
2002: Pieter J Tanis; Omgo E Nieweg; Renato A Valdés Olmos; Johannes L Peterse; E J Th Rutgers; Cornelis A Hoefnagel; Bin B R Kroon
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients.
British journal of cancer 2002;87(7):705-10.
2002: Nina Bijker; Johannes L Peterse; Ian S Fentiman; Jean-Pierre Julien; Augustinus A M Hart; Antoine Avril; L Cataliotti; E J Th Rutgers
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS.
British journal of cancer 2002;87(6):615-20.
2002: Stefania Damiani; Vincenzo Eusebi; Johannes L Peterse
Malignant neoplasms infiltrating pseudoangiomatous' stromal hyperplasia of the breast: an unrecognized pathway of tumour spread.
Histopathology 2002;41(3):208-15.
2002: Gianluca Marucci; Christine M Betts; Rastko Golouh; Johannes L Peterse; Maria P Foschini; Vincenzo Eusebi
Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description.
Virchows Archiv : an international journal of pathology 2002;441(2):117-23.
2002: Serge van Ruth; Frits van Coevorden; Johannes L Peterse; Bin B R Kroon
Alveolar soft part sarcoma. a report of 15 cases.
European journal of cancer (Oxford, England : 1990) 2002;38(10):1324-8.
2002: Eelco de Bree; Frits van Coevorden; Johannes L Peterse; Nicola S Russell; E J Th Rutgers
Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition?
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2002;28(4):392-5.
2002: JG Schrama; Ian F Faneyte; Jan H Schornagel; Joke W Baars; Johannes L Peterse; Marc J van de Vijver; Otilia Dalesio; Harm van Tinteren; E J Th Rutgers; D J Richelt; Sjoerd Rodenhuis
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(5):689-98.
2002: E J Th Rutgers; Johannes L Peterse; Nina Bijker
Ductal carcinoma in situ of the breast; diagnostic assessment and treatment.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2002;91(3):268-72.
2002: Dick van Geldere; Patrick Fa-Si-Oen; Leslie A Noach; Peter J G M Rietra; Johannes L Peterse; Robert P A Boom
Complications after colorectal surgery without mechanical bowel preparation.
Journal of the American College of Surgeons 2002;194(1):40-7.
2001: Omgo E Nieweg; E J Th Rutgers; Liesbeth Jansen; Renato A Valdés Olmos; Johannes L Peterse; K A Hoefnagel; Bin B R Kroon
Is lymphatic mapping in breast cancer adequate and safe?
World journal of surgery 2001;25(6):780-8.
2001: Nina Bijker; Johannes L Peterse; L Duchateau; Jean-Pierre Julien; Ian S Fentiman; C Duval; S Di Palma; J Simony-Lafontaine; I de Mascarel; Marc J van de Vijver
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2263-71.
2001: Pieter J Tanis; R P Boom; Heimen Schraffordt Koops; Ian F Faneyte; Johannes L Peterse; Omgo E Nieweg; E J Th Rutgers; Anton T M G Tiebosch; Bin B R Kroon
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer.
Annals of surgical oncology 2001;8(3):222-6.
2001: Luc J A Strobbe; A Jonk; Augustinus A M Hart; Johannes L Peterse; T Wobbes; Omgo E Nieweg; Bin B R Kroon
The value of Cloquet's node in predicting melanoma nodal metastases in the pelvic lymph node basin.
Annals of surgical oncology 2001;8(3):209-14.
2001: Adri C Voogd; M Nielsen; Johannes L Peterse; Mogens Blichert-Toft; Harry Bartelink; M Overgaard; Geertjan van Tienhoven; K W Andersen; R J Sylvester; JA van Dongen
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1688-97.
2001: Nina Bijker; E J Th Rutgers; Johannes L Peterse; Ian S Fentiman; Jean-Pierre Julien; L Duchateau; JA van Dongen
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2001;27(2):135-40.
2001: Nina Bijker; Johannes L Peterse; L Duchateau; Els C Robanus-Maandag; Cathy A J Bosch; C Duval; S Pilotti; Marc J van de Vijver
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.
British journal of cancer 2001;84(4):539-44.
2001: Nina Bijker; E J Th Rutgers; L Duchateau; Johannes L Peterse; Jean-Pierre Julien; L Cataliotti
Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients.
Cancer 2001;91(3):472-7.
2001: Reini Kaas; Augustinus A M Hart; A P E Besnard; Johannes L Peterse; E J Th Rutgers
Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer.
The British journal of surgery 2001;88(1):123-7.
2000: Pieter J Tanis; Omgo E Nieweg; J W Merkus; Johannes L Peterse; Bin B R Kroon
False negative sentinel node procedure established through palpation of the biopsy wound.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(7):714-5.
2000: C W Elston; John P Sloane; Isabel Amendoeira; N Apostolikas; Jean-Pierre Bellocq; Simonetta Bianchi; W Boecker; G Bussolati; D Coleman; CE Connolly; Peter Dervan; Maria Drijkoningen; Vincenzo Eusebi; D Faverly; Roland Holland; J Jacquemier; Manuela Lacerda; J Martinez-Penuela; C De Miguel; S Mossi; C Munt; Johannes L Peterse; Fritz Rank; A Reiner; M Sylvan; C A Wells; B Zafrani
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.
European journal of cancer (Oxford, England : 1990) 2000;36(14):1769-72.
2000: Stefania Damiani; Gianandrea Pasquinelli; J Lamovec; Johannes L Peterse; Vincenzo Eusebi
Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study.
Virchows Archiv : an international journal of pathology 2000;437(1):74-81.
2000: M H E Doting; Liesbeth Jansen; Omgo E Nieweg; D Albertus Piers; Anton T M G Tiebosch; Heimen Schraffordt Koops; E J Th Rutgers; Bin B R Kroon; Johannes L Peterse; Renato A Valdés Olmos; Jolanda De Vries
Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.
Cancer 2000;88(11):2546-52.
2000: Liesbeth Jansen; Omgo E Nieweg; Johannes L Peterse; Cornelis A Hoefnagel; Renato A Valdés Olmos; Bin B R Kroon
Reliability of sentinel lymph node biopsy for staging melanoma.
The British journal of surgery 2000;87(4):484-9.
2000: Frank J P Hoebers; Jacques H Borger; Augustinus A M Hart; Johannes L Peterse; E J Th; Joos V Lebesque
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.
Cancer 2000;88(7):1633-42.
2000: Jean-Pierre Julien; Nina Bijker; Ian S Fentiman; Johannes L Peterse; V Delledonne; P Rouanet; Antoine Avril; R Sylvester; F Mignolet; Harry Bartelink; JA van Dongen
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Lancet 2000;355(9203):528-33.
1999: CB Vos; Natalja T Ter Haar; Carla Rosenberg; Johannes L Peterse; Anne-Marie Cleton-Jansen; Cees J Cornelisse; Marc J van de Vijver
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type.
British journal of cancer 1999;81(8):1410-8.
1999: W Deenik; Wolter J Mooi; E J Th Rutgers; Johannes L Peterse; Augustinus A M Hart; Bin B R Kroon
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases.
Cancer 1999;86(6):969-75.
1999: Nina Bijker; E J Th Rutgers; Johannes L Peterse; JA van Dongen; Augustinus A M Hart; Jacques H Borger; Bin B R Kroon
Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Cancer 1999;85(8):1773-81.
1999: Omgo E Nieweg; Liesbeth Jansen; Renato A Valdés Olmos; E J Th Rutgers; Johannes L Peterse; K A Hoefnagel; Bin B R Kroon
Lymphatic mapping and sentinel lymph node biopsy in breast cancer.
European journal of nuclear medicine 1999;26(4 Suppl):S11-6.
1999: CB Vos; Natalja T Ter Haar; Johannes L Peterse; Cees J Cornelisse; Marc J van de Vijver
Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
The Journal of pathology 1999;187(3):279-84.
1999: Geertjan van Tienhoven; Adri C Voogd; Johannes L Peterse; M Nielsen; K W Andersen; F Mignolet; Richard Sylvester; Ian S Fentiman; E van der Schueren; K van Zijl; Mogens Blichert-Toft; Harry Bartelink; JA van Dongen
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1999;35(1):32-8.
1999: John P Sloane; Isabel Amendoeira; N Apostolikas; Jean-Pierre Bellocq; Simonetta Bianchi; Werner Boecker; G Bussolati; D Coleman; CE Connolly; V Eusebi; C De Miguel; Peter Dervan; R Drijkoningen; C W Elston; D Faverly; A Gad; J Jacquemier; Manuela Lacerda; J Martinez-Penuela; C Munt; Johannes L Peterse; Fritz Rank; M Sylvan; V Tsakraklides; B Zafrani
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.
Virchows Archiv : an international journal of pathology 1999;434(1):3-10.
1998: Liesbeth Jansen; Omgo E Nieweg; Renato A Valdés Olmos; E J Th Rutgers; Johannes L Peterse; Jolanda De Vries; M H E Doting; Bin B R Kroon
Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1998;24(5):445-6.
1998: Sjoerd Rodenhuis; Dick J Richel; ELSKEN VAN DER WALL; Jan H Schornagel; Joke W Baars; C C Koning; Johannes L Peterse; Jacques H Borger; Willem Nooijen; Roel Bakx; Otilia Dalesio; E J Th Rutgers
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
Lancet 1998;352(9127):515-21.
1997: Wiljo J F De Leeuw; G Berx; CB Vos; Johannes L Peterse; Marc J van de Vijver; Sergey V Litvinov; F Van Roy; Cees J Cornelisse; Anne-Marie Cleton-Jansen
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
The Journal of pathology 1997;183(4):404-11.
1997: BA Kapteijn; Omgo E Nieweg; IH Liem; W J Mooi; Alfons J M Balm; Sara H Muller; Johannes L Peterse; Renato A Valdés Olmos; Cornelis A Hoefnagel; Bin B R Kroon
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye.
Annals of surgical oncology 1997;4(2):156-60.
1997: CB Vos; Anne-Marie Cleton-Jansen; G Berx; Wiljo J F De Leeuw; Natalja T Ter Haar; F van Roy; Cees J Cornelisse; Johannes L Peterse; Marc J van de Vijver
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
British journal of cancer 1997;76(9):1131-3.
1997: Paul Baas; LH Murrer; Frans A N Zoetmulder; Fiona A Stewart; H B Ris; nico van zandwijk; Johannes L Peterse; E J Th Rutgers
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.
British journal of cancer 1997;76(6):819-26.
1997: John P Sloane; Isabel Amendoeira; N Apostolikas; Jean-Pierre Bellocq; Simonetta Bianchi; Werner Böcker; G Bussolati; CE Connolly; C De Miguel; Peter Dervan; R Drijkoningen; C W Elston; D Faverly; A Gad; Roland Holland; J Jacquemier; Manuela Lacerda; A Lindgren; J Martinez-Peñuela; Johannes L Peterse; Fritz Rank; V Tsakraklides; C de Wolf; B Zafrani
[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].
Der Pathologe 1997;18(1):71-88.
1996: ELSKEN VAN DER WALL; E J Th Rutgers; M J Holtkamp; Joke W Baars; Jan H Schornagel; Johannes L Peterse; Jos H Beijnen; Sjoerd Rodenhuis
Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
British journal of cancer 1996;73(9):1080-5.
1996: Rob Michalides; P Hageman; H van Tinteren; L Houben; E Wientjens; R Klompmaker; Johannes L Peterse
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.
British journal of cancer 1996;73(6):728-34.
1995: Wolter J Mooi; W Deenik; Johannes L Peterse; Pancras Hogendoorn
Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma).
Histopathology 1995;27(1):61-5.
1994: E J Th Rutgers; Johannes L Peterse; Harry Bartelink; JA van Dongen
Surgical treatment and deciding definitive management policy in a premenopausal patient with early breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1994;20(5):607-9; discussion 609-10.
1994: R S Cornelis; Marcel van Vliet; CB Vos; Anne-Marie Cleton-Jansen; Marc J van de Vijver; Johannes L Peterse; PM Khan; A L Børresen; Cees J Cornelisse; Peter Devilee
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cancer research 1994;54(15):4200-6.
1994: Roland Holland; Johannes L Peterse; R R Millis; V Eusebi; D Faverly; Marc J van de Vijver; B Zafrani
Ductal carcinoma in situ: a proposal for a new classification.
Seminars in diagnostic pathology 1994;11(3):167-80.
1993: ELSKEN VAN DER WALL; Dick J Richel; Y H Kusumanto; E J Th Rutgers; Jan H Schornagel; C C Schaake-Koning; Johannes L Peterse; Sjoerd Rodenhuis
Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):791-2.
1993: Frans A N Zoetmulder; Jacques H Borger; E J Th Rutgers; R Bergman; Johannes L Peterse; Harry Bartelink
Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation.
European journal of cancer (Oxford, England : 1990) 1993;29A(7):957-61.
1992: Ed Schuuring; Els Verhoeven; H van Tinteren; Johannes L Peterse; B Nunnink; F B Thunnissen; Peter Devilee; C J Cornelisse; Marc J van de Vijver; Wolter J Mooi
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
Cancer research 1992;52(19):5229-34.
1992: M J Hooning; JA van Dongen; Augustinus A M Hart; Johannes L Peterse; E D Bruggink; G Went
Breast cancer: a study into the value of a historical group as comparative material for new methods of treatment.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(1):16-22.
1992: E de Jong; Johannes L Peterse; JA van Dongen
Recurrence after breast ablation for ductal carcinoma in situ.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(1):64-6.
1992: Wolter J Mooi; Johannes L Peterse
Progress in molecular biology of breast cancer.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):623-5.
1992: JA van Dongen; Roland Holland; Johannes L Peterse; I S Fentiman; M D Lagios; R R Millis; A Recht
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):626-9.
1991: E J Th Rutgers; A B van Rossum; Johannes L Peterse; P Cohen; Jacques H Borger; H W Kemperman
Breast-conserving therapy for invasive carcinoma: diagnosis of local recurrence.
The Netherlands journal of surgery 1991;43(4):110-3.
1991: Bart C Vrouenraets; Johannes L Peterse; JA van Dongen
Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases.
The Netherlands journal of surgery 1991;43(3):51-5.
1989: Johannes L Peterse; M A Koolman-Schellekens; T van de Peppel-van de Ham; P van Heerde
Atypia in fine-needle aspiration cytology of the breast: a histologic follow-up study of 301 cases.
Seminars in diagnostic pathology 1989;6(2):126-34.
1988: Marc J van de Vijver; Johannes L Peterse; Wolter J Mooi; P Wisman; J Lomans; Otilia Dalesio; Roel Nusse
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
The New England journal of medicine 1988;319(19):1239-45.
1988: Marc J van de Vijver; Wolter J Mooi; Johannes L Peterse; Roel Nusse
Amplification and over-expression of the neu oncogene in human breast carcinomas.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1988;14(2):111-4.
1988: Harry Bartelink; Jacques H Borger; JA van Dongen; Johannes L Peterse
The impact of tumor size and histology on local control after breast-conserving therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;11(4):297-303.
1988: Johannes L Peterse; JA van Dongen; Harry Bartelink
Recurrence of breast carcinoma after breast conserving treatment.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1988;14(2):123-6.
1988: Marc J van de Vijver; Wolter J Mooi; P Wisman; Johannes L Peterse; Roel Nusse
Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA.
Oncogene 1988;2(2):175-8.